As per the decision of the Capital Markets Board (the “CMB”) published in its bulletin dated 31 December 2024, the financial thresholds required for the companies’ initial public offering have been increased which introduce challenges for small-scale companies aiming for a public offering. Accordingly, the required minimum total assets amount in the financial statements of the companies has been revised as TRY 1,500,000,000 for 2023 and as TRY 2,400,000,000 for 2024 and the minimum net sales revenue amount has been revised as TRY 750,000,000 for 2023 and TRY 1,200,000,000 for 2024 in order to be eligible to apply for public offering.
Also, the minimum capital amount required for transition to the registered capital system has been increased to TRY 150,000,000.
The CMB, through its decision numbered 18/505, published in its weekly bulletin dated 28 March 2024, and numbered 2024/17, had decided to reduce the public offering monetary thresholds in relation to total assets and net sales revenues of issuers, limited to companies operating in the energy, chemical, agriculture, and defense industries, as well as those providing advanced technology-based solutions.
For the year 2025, the CMB continues to implement sector-specific public offering facilitation measures. The monetary thresholds applicable to companies within the scope of the decision stated above have been revised as follows:
TRY | For the Year of 2023 | For the Year of 2024 |
Net Sales Revenue | 270,000,000 | 600,000,000 |
Total Assets | 450,000,000 | 1,200,000,000 |
On 31 December 2024, the listing requirements have been also updated with the revisions made in the Listing Directive of Borsa Istanbul. Accordingly, minimum market value of shares offered to public has been increased as follows:
- from TRY 1,000,000,000 to TRY 2,000,000,000 for companies quoted in the Star Market,
- from TRY 250,000,000 to TRY 500,000,000 for companies quoted in the Main Market,
- from TRY 100,000,000 to TRY 200,000,000 for companies quoted in the Sub-Market.
Moreover, for listing applications submitted for the Star Market, in cases where the market value of shares offered to public exceeds TRY 6,000,000,000, minimum ratio of nominal value of shares offered to public to the share capital has been decreased from 10% to 6%.
For the initial listing of the merged company’s shares to be issued through public offering, the minimum market value of shares offered to public has been increased from TRY 200,000,000 to TRY 2,000,000,000.
Pursuant to the Listing Directive of Borsa Istanbul, the board of Borsa İstanbul holds the authority to approve the listing of issuers in the Star Market, even if they do not meet the annual profit in the independently audited annual financial statements and/or the equity capital ratio in the latest independently audited financial statements, provided that specific alternative conditions are fulfilled that are outlined in the Listing Directive. For such issuers, minimum market value of shares offered to public is increased from TRY 1,500,000,000 to TRY 4,000,000,000.
Share
Related persons
You can contact us for detailed information.
Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
13 January 2025
New Administrative Fines Regulation For Competition Violations Enters Into Force
The Regulation on Administrative Fines for Restrictive Agreements, Concerted Practices, Decisions, and Abuse of Dominance, which governs…
9 January 2025
Türkiye Strengthens Anti-Money Laundering Standards for Crypto Assets
Following the legal framework established for crypto assets and crypto asset service providers ("CASPs") under the Capital Markets Law No.…
30 December 2024
Legal Briefing on Recent Developments in the Electricity Market
With the Regulation on Aggregation Activities in the Electricity Market, published in the Official Gazette dated 17 December 2024 and…
23 December 2024
Transfer of Marketing Authorisations for Medicinal Products
Under Turkish law, only entities registered in Türkiye are eligible to obtain a marketing authorization (“MA”) for medicinal products for…
20 December 2024
Amendments to Turkish Sustainability Reporting Standarts
The decision of the Public Oversight, Accounting, and Auditing Standards Authority (the “Decision”) on determining the scope of application…
12 December 2024
Recent Developments in Healthcare Legislation – 2024 Fall Issue
On 28 May 2024, Turkish Medicines and Medical Devices Agency (“Agency”) has shared the Draft Regulation on the Promotional Activities of…